Peptide purity is the single most important quality parameter for any research application. Impurities can confound experimental results, introduce toxicity, and invalidate entire studies. This guide provides a comprehensive overview of purity testing methods, how to read Certificates of Analysis (COAs), and what standards to expect from reputable suppliers.
High-Performance Liquid Chromatography (HPLC) is the gold standard for peptide purity analysis. This technique separates peptide molecules based on their interaction with a stationary phase, producing a chromatogram that reveals the proportion of target peptide versus impurities. A well-resolved HPLC trace should show a single dominant peak representing the desired peptide, with minimal secondary peaks.
When reading an HPLC report, the key metric is percent purity, typically calculated as the area of the target peak divided by the total area of all peaks. For research-grade peptides, a purity of ≥95% is generally considered acceptable. For applications requiring higher precision, such as in vivo studies, purities of ≥98% or even ≥99% may be warranted.
Mass spectrometry (MS) complements HPLC by confirming the molecular identity of the peptide. While HPLC tells you how pure the sample is, MS tells you whether the major peak actually corresponds to the correct molecule. The most common technique is electrospray ionization mass spectrometry (ESI-MS), which generates a mass-to-charge ratio spectrum that should match the theoretical molecular weight of the target peptide.
A complete Certificate of Analysis should include: the peptide name and sequence, lot or batch number, HPLC chromatogram with percent purity, mass spectrometry data showing observed vs. expected molecular weight, appearance description, solubility data, and any additional testing relevant to the specific peptide (such as endotoxin testing for injectable preparations).
Common impurities in synthetic peptides include deletion sequences (peptides missing one or more amino acids), truncated sequences, oxidized forms, and residual solvents or reagents from the synthesis process. Understanding the nature of these impurities can help researchers assess whether they're likely to affect experimental outcomes.
Amino acid analysis (AAA) is an additional quality control method that quantifies the amino acid composition of a peptide sample. By hydrolyzing the peptide and measuring the individual amino acids, AAA provides independent confirmation that the correct sequence was synthesized. This method is particularly valuable for peptides where sequence errors could mimic the activity of the target compound.
Endotoxin testing is essential for any peptide intended for cell culture or in vivo research. Bacterial endotoxins can trigger potent immune responses that confound experimental results. The Limulus Amebocyte Lysate (LAL) test is the standard method, with acceptable levels typically below 1 EU/mg for research applications.
Counterion content is an often-overlooked aspect of peptide quality. Most synthetic peptides are supplied as trifluoroacetate (TFA) or acetate salts. The counterion contributes to the total weight of the sample, meaning that the actual peptide content may be significantly lower than the weight on the label. This is important for accurate dosing in research protocols.
Red flags when evaluating a peptide supplier include: COAs that lack chromatograms or raw data, unusually low pricing without explanation, inability to provide batch-specific documentation, and claims of purity without specifying the analytical method used. Reputable suppliers provide detailed, batch-specific analytical data and are transparent about their manufacturing processes.
For researchers new to peptide procurement, the investment in understanding purity testing pays significant dividends in experimental reliability and reproducibility. Requesting and carefully reviewing COAs for every batch should be standard practice in any peptide research program.
